SCHEMBL30775627

SCHEMBL30775627

C[C@@H](O)[C@H](NCC1CCCCC1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
EPHX1 P07099 4/20 0.41
LTA4H P09960 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
CA9 Q16790 1/20 0.39
EPHX2 P34913 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
ADH1B P00325 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20999947 1.00 CYP2D6 (0.41) CYP2D6EPHX1LTA4HALDH1A1SMN1; SMN2
SCHEMBL7389974 0.88 ALDH1A1 (0.47) CYP2D6EPHX1LTA4HALDH1A1SMN1; SMN2
SCHEMBL30775639 0.83 TSHR (0.43) CYP2D6EPHX1ALDH1A1CA12CA1
SCHEMBL4619210 0.80 LTA4H (0.47) CYP2D6EPHX1LTA4HCA12CA1
SCHEMBL4620202 0.80 LTA4H (0.47) CYP2D6EPHX1LTA4HCA12CA1
SCHEMBL4620196 0.80 LTA4H (0.47) CYP2D6EPHX1LTA4HCA12CA1
SCHEMBL22413011 0.78 LTA4H (0.44) CYP2D6EPHX1LTA4HALDH1A1SMN1; SMN2
SCHEMBL22413014 0.78 LTA4H (0.44) CYP2D6EPHX1LTA4HALDH1A1SMN1; SMN2
SCHEMBL6138081 0.77 HPGD (0.46) EPHX1LTA4HALDH1A1SMN1; SMN2EPHX2
SCHEMBL6138080 0.77 HPGD (0.46) EPHX1LTA4HALDH1A1SMN1; SMN2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117177744-A CDK2 inhibitors and methods of use thereof 塞迪拉治疗股份有限公司 2023-12-05 CN disclosed